Wellcome statements on Covid-19
Statements issued by Wellcome in response to the Covid-19 pandemic.
Statements issued by Wellcome in response to the Covid-19 pandemic.
Wellcome's new discovery research schemes will give researchers the time, freedom and financial resources to pursue the ideas that will improve human health
Wellcome is pledging up to US$100m (£70m/€80m) to accelerate Covid-19 research and development to ensure science keeps pace with the virus.
Wellcome's response to some journals discouraging researchers from making Author Accepted Manuscripts open access.
Our Director Jeremy Farrar responds to the publication of the Integrated Review.
Gabriel Leung, University of Hong Kong, and Arup K. Chakraborty, Massachusetts Institute for Technology, will join Wellcome's Board of Governors in May 2021.
Cheryl Moore, currently President and Chief Operating Officer of the New York Genome Center, is to take up the role of Director, Research Programmes at Wellcome.
We’re reshaping the organisation around our new goals and developing a new structure at Wellcome.
How Wellcome's investment portfolio performed in the year to 30 September 2020.